Hangzhou Tigermed Consulting Co Ltd is a CN-based company operating in Life Sciences Tools & Services industry. The company is headquartered in Hangzhou, Zhejiang and currently employs 10,185 full-time employees. The company went IPO on 2012-08-17. Hangzhou Tigermed Consulting Co Ltd is a China-based holding company engaged in providing clinical trial services for research and development of new drugs. The firm operates two segments. The Clinical Trial Solutions segment provides clinical trial operation services and medical translation services to biopharmaceutical and medical device companies and thus help them conduct clinical trials of innovative drugs, generic drugs and medical devices. The Clinical-Related and Laboratory Services segment is involved in provision of analytical services, such as data management and statistical analysis; logistics and execution support services, such as clinical trial site management; administrative assistance, such as patient recruitment; as well as consulting services. This segment also provides laboratory services for preclinical and clinical development stages through its subsidiary. The firm conducts its businesses in the domestic and overseas markets.
Follow-Up Questions
HTMDF 주식의 가격 성능은 어떻습니까?
HTMDF의 현재 가격은 $0이며, 전 거래일에 decreased 0% 하였습니다.
Hangzhou Tigermed Consulting Co Ltd의 주요 사업 주제나 업종은 무엇입니까?
Hangzhou Tigermed Consulting Co Ltd은 Life Sciences Tools & Services 업종에 속하며, 해당 부문은 Health Care입니다
Hangzhou Tigermed Consulting Co Ltd의 시가총액은 얼마입니까?
Hangzhou Tigermed Consulting Co Ltd의 현재 시가총액은 $0입니다
Hangzhou Tigermed Consulting Co Ltd는 매수, 매도, 아니면 보유해야 하나요?
월스트리트 분석가들에 따르면, 12명의 분석가가 Hangzhou Tigermed Consulting Co Ltd에 대한 분석 평가를 실시했으며, 이는 3명의 강력한 매수, 10명의 매수, 4명의 보유, 2명의 매도, 그리고 3명의 강력한 매도를 포함합니다